Skip to Main Content
Services Talent Knowledge
Site Search
Menu

Events

July 16, 2014

Asset Purchase Agreements

Hiscock & Barclay Partner John P. Lowe, Jr. will present at this moderated re-broadcast of the National Business Institute Teleconference, Asset Purchase Agreements.

Master the Skill of Drafting Through Asset Purchase Agreements

An asset purchase is one of the ways to execute an acquisition, and drafting a detailed purchase agreement is vital to the success of the transaction. Taking the time to draft necessary provisions and foresee post-deal problems can bring quick solutions to disputes and help avoid litigation. Join our experienced faculty as they walk you through drafting an asset purchase agreement from start to finish. Register today!

  • Learn why buyers prefer asset transactions.
  • Recognize the importance of drafting thorough provisions.
  • Gain a clear understanding of indemnification in purchase agreements.

This is a moderated re-broadcast of the original teleconference delivered by Mr. John P. Lowe, Jr. on October 21, 2013. At the conclusion of the call, Mr. Lowe will field questions in a formal question and answer session.

Who Should Attend: This course is designed for attorneys.

Course Content

  1. Why an Asset Deal?
  2. Drafting an Asset Purchase Agreement

Continuing Legal Credit Available

For more information, go to the NBI website by clicking here.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Massachusetts Federal Court Permits Sharing Clause in Protective Order in Products Liability Case

Alerts

NYS Court of Appeals Holds That Parent May Not Recover for Emotional Injuries in Prenatal-Injury Case

Alerts

Smarter Inventory Management for Pharmacies: Navigating Online Marketplace Compliance

Alerts

Emergency Wine Run, Now Legal: New York State Opens Retail-to-Retail Sales

Alerts

California's Updated Privacy Regulations: Automated Decisionmaking Technology, Cybersecurity Audits, and Risk Assessments, Part 1

Alerts

Pharmacies on High Alert: Optum Rx's 25-Percent Therapeutic-Class Cap Creates Major Legal, Operational, and Competitive Risks